At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIAF bioAffinity Technologies, Inc.
Post-Mkt 12-11 17:55:09 EST
1.66
-0.03
-1.78%
盘后1.64
-0.02-1.20%
17:43 EST
High1.69
Low1.65
Vol42.66K
Open1.65
D1 Closing1.69
Amplitude2.37%
Mkt Cap7.47M
Tradable Cap5.65M
Total Shares4.50M
T/O71.01K
T/O Rate1.25%
Tradable Shares3.40M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
bioAffinity Technologies Showcases CyPath Lung Test Success in Early Lung Cancer Detection at NLCRT
Wallachbeth Capital Announces the Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.